Lyme Innovation and Health Equity:
Data-Driven, Patient-Centered Innovation for Tick-Borne Diseases
- State and Local Data Viz: Lyme disease cases are reported by county and states, yet
policy and budget decisions often happen at the level of U.S.
Congressional districts, so what innovative maps and extrapolation methods
can map case counts to Congressional districts?
- Inclusive Education: Develop Lyme disease
prevention and education tools, including inclusive materials for racial
and ethnic minorities to recognize the Lyme “bullseye” rash (i.e.,
erythema migrans or EM) on all skin types.
- Lyme Disease and COVID-19: Lyme disease is a multisystemic, inflammatory, complex
condition with multiple disease states, including patients with enduring
symptoms after antibiotic treatment where no definitive diagnostics exist
today. Might COVID-19 technologies and insights, including those from the
Long COVID community, be adapted or repurposed for Lyme and tick-borne
Innovation: Transform datasets into novel
insights, decision support, digital tools, data visualizations, or other
innovations to support patients, aid practitioners, or address
socioeconomic and systemic challenges for equitable access to quality